Kimberly Chew will present, "Controlled Substances Law – Beyond the Stereotypes: Rescheduling/Redux," at the Practising Law Institute.
This Studio Briefing addresses practical legal considerations following the Department of Justice notice of proposed rulemaking to reschedule marijuana from Schedule I to Schedule III, under the Controlled Substances Act. Panelists address some of the immediate and longer-term implications of the proposal, relevant federal agency coordination and how counsel can prepare for certain developments that may impact manufacturers, companies, consumers, patients and other related parties.
Topics:
- Review the role of federal agencies: DOJ-DEA, HHS-FDA
- Understand related statutes and regulations/rulemaking
- Explain schedule 1 and schedule 3 under the Controlled Substances Act
- Assess considerations and practical implications for manufacturers-companies, individuals-consumers, patients, etc.
For more information or for online viewing, visit the program website.